Dong Ki Lee, PhDOliX Pharmaceuticals における Founder and CEOスピーカー
プロフィール
Dong Ki Lee, Ph.D. is the Chief Executive Officer of OliX Pharmaceuticals, a biotechnology company developing next-generation RNAi therapeutics. He received his B.S. in Chemistry from KAIST and his Ph.D. in Molecular Biology from Cornell University, establishing a strong foundation in both chemistry and life sciences. He is also a Professor of Chemistry at Sungkyunkwan University, where he contributes to teaching and research. At OliX, he leads the development of the company’s proprietary asiRNA platform and oversees multiple therapeutic programs addressing significant unmet needs. His work focuses on advancing RNAi technologies toward clinical applications and translating innovative oligonucleotide platforms into impactful therapies.